Startup Scout 6 Apr 2018 Spanish Biotech Uses Microbes to Make Biofuels, Food and Detergents Today, we’re in Granada, Spain, to visit Neol Bio. The biotech recycles waste to produce oils for biofuels, nutritional supplements and cleaning detergents by culturing microorganisms with waste. Mission: Neol Bio develops sustainable ways of producing oils for a wide variety of applications, from food supplements to cleaning detergents and bioenergy. The company uses high-throughput screening to […] April 6, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
More News! 5 Apr 2018 French Crossover Fund Raises €275M to Invest in Medical Biotechs Sofinnova Partners has launched a crossover fund focusing on European companies to support medical biotechs across all funding stages, from seed to late stage. Sofinnova Partners, the largest French biotech VC, has launched a new fund called Sofinnova Crossover I to invest in the biopharmaceutical and medical device sectors. According to Sofinnova, the €275M fund […] April 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2018 First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US Curetis is the first company to receive FDA approval to market a molecular diagnostic test for lung infections in the US. The test reduces the time taken to reach a diagnosis from several days under five hours. The FDA has given Curetis, a German biotech, the green light to launch its first-in-class Unyvero platform for diagnosing lung infections […] April 4, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 29 Mar 2018 What Are the Best Funding Strategies for Biotech Startups? Funding a biotech startup is no easy task and can influence the long-term success of a company. Here are some of the do’s and don’ts of successful biotech fundraising. Learning from failures can be valuable in almost any pursuit, and biotech funding strategies are no exception. For example, when a startup is in the initial stages of […] March 29, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 28 Mar 2018 AI Is Being Put to Work to Treat Parkinson’s Disease in the UK The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is collaborating with Parkinson’s UK and The Cure Parkinson’s Trust (CPT), two UK charities, to repurpose at least three existing drugs and identify two novel drug targets […] March 28, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2018 A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis Angle, a UK-based biotech, is developing a non-invasive liquid biopsy that could be better than current diagnostic methods at predicting ovarian cancer. Angle, a company specializing in liquid biopsies, has shown that its Pelvic Mass Triage (PMT) liquid biopsy test can differentiate between benign and cancerous pelvic masses and ovarian cysts in 95% of cases […] March 27, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2018 New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German biotech, has obtained positive Phase II trial results for its lead antibiotic candidate for treating urinary tract infections. The drug, AAU101, was given to patients intravenously with cefepemine, another antibiotic […] March 26, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2018 Biotech VC Goes After Disrupting Animal Health and Nutrition The French biotech VC Seventure, known for its investments in microbiome health, has launched a €24M fund focused on companies developing animal health and nutrition applications. A new venture capital fund called AVF has been launched today to support animal health and nutrition companies. With €24M at its first closing, the fund created by Seventure Partners in partnership […] March 23, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2018 Researchers Give Sight to the Blind With Stem Cell Patch UK researchers have successfully restored vision in two blind patients by transplanting a stem cell patch into their eyes. Scientists at University College London and Moorfields Eye Hospital, London, have used a stem cell patch to successfully restore vision in two patients with age-related macular degeneration (AMD) in a Phase I trial. Following the stem […] March 23, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2018 French Biotech Signs a Deal to Fight Antibiotic Resistance Deinove is licensing a portfolio of antibiotics for multi-drug resistant bacteria from Redx Pharma. Deinove, based in Montpellier, France, has signed an agreement to use synthetic molecules developed by UK biotech Redx to treat lethal anitbiotic-resistant infections. Redx’s molecules are a new class of antibiotics targeting an enzyme involved in bacterial DNA replication in Gram-negative bacteria. Deinove plans to […] March 22, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2018 A Personalized Genetic Test for Breast Cancer Arrives in Europe Agendia will launch a next-generation sequencing test in the EU to determine the chances of metastasis in breast cancer patients. Agendia, a US-Dutch biotech specializing in personalized medicine and molecular diagnostics, has obtained CE marking for the MammaPrint BluePrint Kit, a diagnostic device for breast cancer that uses next-generation sequencing technology. The kit can help clinicians identify […] March 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 21 Mar 2018 Do Phages Hold the Key to Modulating the Microbiome? The human microbiome is emerging as a target for treating a wide range of diseases, but it’s still a young field and there are lots of unknowns. Philip discussed with the CEO of BiomX whether phages may be the key to targeting specific bacterial strains in the microbiome. In the last decade, scientists have found […] March 21, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email